Harvard Bioscience Inc (HBIO) Insider Trading
- $2,036,005.00
- $10,851,189.22
- March 17, 2026
- David Green
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 7, 2018 | CFO | 97,087 | $4.62 | Sell | $448,541.94 | |
| June 12, 2017 | CEO | 22,000 | $2.76 | Buy | $60,720.00 | |
| June 8, 2017 | Director | 7,712 | $2.55 | Buy | $19,665.60 | |
| May 26, 2017 | CFO | 1,000 | $2.33 | Buy | $2,330.00 | |
| May 25, 2017 | Director | 12,238 | $2.35 | Buy | $28,759.30 | |
| May 24, 2017 | Director | 10,000 | $2.38 | Buy | $23,800.00 | |
| Feb. 7, 2017 | Director | 3,239 | $3.25 | Sell | $10,526.75 | |
| Feb. 6, 2017 | Director | 1,288 | $3.25 | Sell | $4,186.00 | |
| Dec. 6, 2016 | Director | 23,088 | $2.42 | Sell | $55,872.96 | |
| Nov. 3, 2016 | CEO | 15,000 | $2.42 | Buy | $36,300.00 | |
| Nov. 3, 2016 | CFO | 25,000 | $2.34 | Buy | $58,500.00 | |
| Dec. 10, 2015 | CEO | 10,000 | $3.37 | Buy | $33,700.00 | |
| Dec. 3, 2015 | Director | 3,000 | $3.32 | Buy | $9,960.00 | |
| Nov. 9, 2015 | CFO | 3,000 | $3.08 | Buy | $9,240.00 | |
| Sept. 2, 2015 | CEO | 2,000 | $4.41 | Buy | $8,820.00 | |
| Sept. 1, 2015 | Director | 2,000 | $4.33 | Buy | $8,660.00 | |
| July 17, 2015 | Director | 17,103 | $5.26 | Sell | $89,961.78 | |
| July 14, 2015 | Director | 51,597 | $5.28 | Sell | $272,432.16 | |
| April 23, 2015 | Director | 118,500 | $6.03 | Sell | $714,555.00 | |
| April 22, 2015 | Director | 123,997 | $6.23 | Sell | $772,501.31 | |
| April 17, 2015 | Director | 42,503 | $6.55 | Sell | $278,394.65 | |
| April 14, 2015 | Director | 80,168 | $6.61 | Sell | $529,910.48 | |
| Feb. 9, 2015 | Director | 48,712 | $5.25 | Sell | $255,738.00 | |
| Dec. 30, 2014 | Director | 16,173 | $5.25 | Sell | $84,908.25 | |
| Dec. 29, 2014 | Director | 100,167 | $5.25 | Sell | $525,876.75 | |
| Dec. 22, 2014 | Director | 80,202 | $5.02 | Sell | $402,614.04 | |
| Nov. 19, 2014 | Director | 10,000 | $4.95 | Sell | $49,500.00 | |
| Oct. 31, 2014 | Director | 117,654 | $4.97 | Sell | $584,740.38 | |
| June 16, 2014 | CFO | 5,000 | $3.86 | Buy | $19,300.00 | |
| May 29, 2014 | Director | 12,317 | $3.82 | Sell | $47,050.94 | |
| April 9, 2014 | Director | 27,540 | $4.47 | Sell | $123,103.80 | |
| April 8, 2014 | Director | 66,090 | $4.48 | Sell | $296,083.20 | |
| April 3, 2014 | Director | 63,501 | $4.63 | Sell | $294,009.63 | |
| Aug. 27, 2013 | Major Shareholder | 60,000 | $5.00 | Buy | $300,000.00 |
Insiders are both buying and selling Harvard Bioscience Inc stock.
The insider traders at Harvard Bioscience Inc are: David Green, Jeffrey Duchemin, Robert E. Gagnon, James W Green, Bertrand Loy, James W. Green, Robert E Gagnon, George Uveges, Earl R. Lewis, William Snider, John D Duke, Alan I. Edrick, Chane Graziano, Alan I Edrick, John F Kennedy, Katherine A. Eade, Neal J Harte, Stephen J Denelsky, Thomas W. Loewald, and Value Fund Lp Palogic
The most active insider trader at Harvard Bioscience Inc is David Green with 17 trades.
David Green has sold the most Harvard Bioscience Inc stock with a total value of $5,299,568.93.
James W Green has bought the most Harvard Bioscience Inc stock with a total value of $657,900.00.
The most recent insider trade for Harvard Bioscience Inc was on March 17, 2026.
The single biggest insider buy for Harvard Bioscience Inc was from Chane Graziano with a total value of $300,000.00 on Aug. 27, 2013.
The single biggest insider sell for Harvard Bioscience Inc was from Jeffrey Duchemin with a total value of $927,000.00 on Aug. 9, 2018.